Most studies were focused on evaluating t-Tau alone or combined with other biomarkers, such as Aβ, neurofilaments light chain (NfL), S100, and GFAP, thus comparing differences in MS population between neuronal and astrocytic proteins [23,25,28,32,33]. The gene discussed is NEFL; the disease is myeloid sarcoma.